Roundhill Memory ETF (DRAM) — Available-Data Snapshot
Updated Sep 3, 2026 · available-data snapshot · descriptive, not a DCF, not advice
We don't publish a discounted-cash-flow fair value for Roundhill Memory ETF (DRAM) because the free data sources we rely on don't expose the multi-year financials a DCF needs — common for small or thinly-covered listings. Rather than invent numbers, this page shows an honest snapshot of what the public data does support: the current price and size, any relative valuation multiples that exist, a book-value view, and a price-based read. Treat it as a descriptive starting point, not a valuation and not investment advice.
On the numbers we do have, DRAM trades at a recent price of $56.21, sitting 54% of the way up its 52-week range ($26.14–$81.34), on the Cboe US.
The standard alternative to a DCF is relative valuation — comparing DRAM's trading multiples against no mapped peer set. Here that gives P/E of 25.6×. A cheaper multiple than peers can flag a discount or a market that expects weaker growth; it is a comparison, not a recommendation.
Finally, a price-based read — explicitly not a valuation. DRAM is in a mixed trend, trading -30.9% from its 52-week high. Moving-average trend and 52-week position describe where the stock has traded; they say nothing about what it is worth.
What's missing and why: we can't build a DCF for DRAM because the data source doesn't reliably provide market cap, shares outstanding, revenue (ttm), book value. We would rather say so plainly than manufacture a precise-looking number from nothing. As coverage improves, or for larger and more widely-followed listings, a full intrinsic-value model becomes possible.
Relative valuation — DRAM vs peers
| Multiple | DRAM | Peer median | |
|---|---|---|---|
| P/E | 25.6× | — |
No peer set mapped — showing the ticker's own multiples.
Price-based snapshot
Price-based, not a valuation. Moving-average trend and 52-week position describe where the stock has traded — they say nothing about fair value.
Companies people research alongside DRAM
Explore more
Most undervalued stocks (per our valuation) · All valued stocks · Interactive DRAM viewA descriptive, available-data snapshot and relative comparison — NOT a DCF, NOT a price target, and NOT investment advice. TickerWorth is an educational tool, not a licensed investment adviser. Figures are estimates derived from public market data and can be wrong, stale or incomplete.